Sunshine Novo announced on December 16 that the company and Peking University Medical Department signed the “Peking University Medical Department and Beijing Yangguang Nuohe Pharmaceutical Research Co., Ltd. to jointly establish the “Peking University Medicine-Yangnuohe Innovative Drug Joint Laboratory”. The two sides will focus on cutting-edge fields such as cell therapy and gene therapy, with the core goal of developing clinical drug candidates, giving full play to their respective advantages and collaborating to promote the company's high-quality development in the field of innovative drug research and development.

Zhitongcaijing · 1d ago
Sunshine Novo announced on December 16 that the company and Peking University Medical Department signed the “Peking University Medical Department and Beijing Yangguang Nuohe Pharmaceutical Research Co., Ltd. to jointly establish the “Peking University Medicine-Yangnuohe Innovative Drug Joint Laboratory”. The two sides will focus on cutting-edge fields such as cell therapy and gene therapy, with the core goal of developing clinical drug candidates, giving full play to their respective advantages and collaborating to promote the company's high-quality development in the field of innovative drug research and development.